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EFFECT OF CAFFEINE SUPPLEMENTATION ON VERTICAL JUMP PERFORMANCE,
HEART RATE VARIABILITY, AND ELECTROMYOGRAPHY
Collin T. Garner, M.S.
Western Michigan University, 2019

Research into caffeine’s ability to improve anaerobic performance is inconclusive.
Eleven anaerobically trained individuals (mean age: 23.45 ± 1.51 years) participated in this
study. Assessments of resting heart rate variability (HRV), exercise heart rate variability, surface
electromyography (sEMG), static vertical jump (SJ), and countermovement vertical jump (CMJ)
were conducted before and after administration of placebo and caffeinated treatments. Three
trials of each vertical jump technique were performed before and after treatment administration.
A 60-minute absorption period was utilized for absorption of the treatment following its
ingestion. All participants performed testing on two separate occasions, once under the placebo
condition and once under caffeinated condition.
Statistically significant improvements were found between pre and post-treatment
measures of peak CMJ height (p=0.001), peak CMJ power (p<0.001), eccentric utilization ratio
(p=0.025) in the caffeine condition and eccentric utilization ratio (p=0.013) in the placebo
condition as well as between conditions for peak CMJ height (p=0.018) and peak CMJ power
(p<0.001). No significant differences were found between pre and post-treatment nor conditions
for peak sEMG, high and low frequency power of HRV, peak SJ height, and peak SJ power
(p>0.05). This study concluded that caffeine does appear to improve performance of the vertical
jump but does not appear to significantly change peak sEMG or frequency domain measures of
HRV.
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INTRODUCTION
Caffeine as an Ergogenic Aid
Caffeine is a commonly used stimulant that is often found in many beverages, foods, and
supplements. Many supplements marketed to fitness enthusiasts claim to improve exercise
performance or exercise quality. Some supplements are referred to as a pre-workout supplement
and include caffeine as an ingredient. The current body of research focusing on caffeine’s
performance enhancement has demonstrated its ergogenic effects on aerobic exercise
performance (Graham & Spriet, 1991). However, the research focusing on the efficacy of
caffeine as an ergogenic aid to the performance of anaerobic exercise is inconclusive.
Researchers have suggested that caffeine does not benefit the performance of anaerobic exercise
(Pfeifer et al., 2017; Anderson et al., 2018; Greer, Morales, and Coles, 2006). However, results
from various studies have suggested that caffeine may provide significant benefits to anaerobic
exercise performance in individuals that regularly perform anaerobic training (Glaister et al.,
2008; Bellar et al. 2011; Bloms et al., 2016; Chen et al., 2015). Several studies have assessed
caffeine supplementation as an ergogenic aid for performance of the vertical jump. Such studies
report caffeine’s efficacy for improvement of vertical jump performance that are somewhat
mixed as the research focuses on other modes of anaerobic performance. On one hand, caffeine
has been suggested to be an effective ergogenic aid to vertical jump performance (Foskett, Ali,
and Gant, 2009; Del Coso, et al., 2014; and Bloms, et al., 2016). On the other hand, caffeine was
reported to be ineffective as an ergogenic aid to vertical jump performance (Pfeifer et al., 2017).
This study will assess pre-exercise caffeine ingestion on heart rate variability, electromyography,
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and vertical jump performance. Each of these variables will be defined and explained in relation
to caffeine and its effect on anaerobic performance.
Heart Rate Variability (HRV)
HRV is the measurement of the variations in the amount of time that elapses between
individual beats of the heart (Bigger et al., 1996) via analysis of heart rate monitoring. Data
referring to the standard deviation of the amount of time that occurs between the beats of the
heart is referred to as time-domain data. In addition to time-domain data, analysis of HRV
provides information related to the activity of the autonomic nervous system; referred to as
frequency-domain data (Bigger et al., 1996; Tarvainen et al., 2014; Lopes and White, 2006). The
frequency-domain data present spectral estimations that communicate the influences of
autonomic nervous activity (Lopes and White, 2006). The spectral estimations consist of three
frequency bands: high (0.15-0.4 Hz), low (0.04-0.15 Hz), and very-low (0-0.04 Hz). The high
frequency band is considered to represent parasympathetic activity, the low frequency band is
thought to be representative of a combination of parasympathetic and sympathetic activity, and
the very low frequency band is thought to be indicative of alterations in heart rate that are
influenced by thermoregulatory, vasomotor, and circadian factors (Lopes & White, 2006). The
measure of absolute power, reported in ms2 units, of each individual frequency band, as well as
the total power, reported in ms2 units, of all frequency bands, are recorded. The normalized units
(n.u.), calculated using the powers of the individual frequency bands and the total power, are
calculated for the high frequency and low frequency bands. The calculation of the normalized
units of the high frequency and low frequency bands requires the absolute power of the very-low
frequency band to be subtracted from the total power.
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HRV has been related to skeletal muscle health and functioning by research that has
found a relationship between HRV and risk of musculoskeletal injury. (Gisselman et al., 2016;
Williams et al., 2017). The results of a study using CrossFitTM athletes conducted by Williams
and colleagues (2017) suggests that decreases in the natural logarithm of the root mean square of
the standard deviation of R-R intervals (Ln RMSSD) is accompanied by an increased risk of
overuse injury. Another study conducted by Borchini and colleagues (2018) found that nurses
classified as perceiving the stress levels of their work as high showed significant decreases in the
powers of both high and low frequency measures of HRV. Recently, research has identified
HRV as a useful tool for monitoring recovery, establishing training loads, and estimating risk of
acute injury (Williams et al., 2017; Kiviniemi et al., 2007). The prior research on HRV suggests
that HRV may be associated with the functioning of several aspects of the nervous system;
including elements that may be linked with performance of exercise.
Additionally, caffeine has been shown to directly affect the frequency domain indices of
heart rate variability. The results of Yeragani and colleagues’ (2005) research suggested that
caffeine increases the power of the high frequency measures following the performance of
exercise and low frequency power during exercise when compared to a placebo treatment;
suggesting that caffeine ingestion can alter frequency domain measures of heart rate variability
by causing greater vagal withdrawal and stimulating the sympathetic nervous system.
Alternatively, a study assessing the acute effects of caffeine on heart rate variability suggests that
caffeine ingestion results in a decrease in both high and low frequency power (Sondermeijer et
al., 2002). A study conducted by Porges (1973) builds further upon the relationship between
measures of HRV and other aspects of nervous system functioning as the participants within the
study that had the highest measurements of HRV had the fastest reaction times. HRV is regarded
3

as a valuable measure for drawing inferences of cardiac health, and the frequency domain
measures provide insight into the functioning of the parasympathetic and sympathetic divisions
of the autonomic nervous system (Lopes and White, 2006). The growing popularity of using
HRV measures to monitor recovery and set training loads has resulted in the development of
numerous commercial products that monitor HRV and, in some instance, even provide
information to the user of the product regarding readiness for physical activity. Little research
has been conducted with the purpose of identifying the effects of caffeine on HRV at rest or
during ballistic activities; the primary focus of research into how caffeine affects HRV are on
HRV during and after bouts of aerobic exercise or special populations that may be at elevated
risk of autonomic dysfunction. Given the nature of the previous research relating to HRV, it was
determined that further investigations into HRV’s relationship to performance and the effect that
caffeine supplementation may have on the frequency domain measures of HRV are required.
This study explored whether frequency domain measures of HRV may be associated with
anaerobic performance via caffeine supplementation and vertical jump assessments.
Caffeine and Electromyography
Research focusing on caffeine’s effects on electromyographic activity has produced varied
results. One study conducted by Greer, Morales, and Coles (2006) that sought to investigate
whether caffeine supplementation results in increased motor unit excitability during maximal
intensity anaerobic exercise (specifically, the Wingate Anaerobic Test) reported that no
electromyographic increases in the vastus lateralis and gastrocnemius at time points that
corresponded with peak or minimum power were observed. Alternatively, several studies have
reported that caffeine supplementation does result in a significant increase in electromyographic
activity (Collier, Hardy, Millard-Stafford, and Warren, 2015; Bazzucchi, Felici, Montini, Figura,
4

and Sacchetti, 2011; & Chen, Wang, Tung, and Chao, 2015). It may be the case that significant
increases in electromyographic activity may be observed only when significant improvements in
performance occur, thus limiting the detection of increased electromyographic activity to
scenarios where concurrent improvements in force production or power output occur.
Significance of This Research
The mechanisms underlying aerobic performance enhancement via caffeine
supplementation have been thoroughly explored. However, due to the ambiguity of caffeine’s
benefits to anaerobic performance, the efficacy of caffeine supplementation as an ergogenic aid
benefitting anaerobic performance is a topic of debate and the potential mechanisms underlying
any performance enhancement require further research. This study provides additional research
regarding the efficacy of caffeine’s supplementation with the intention of improving anaerobic
performance. Analysis of data related to physiological mechanisms may suggest what
mechanisms produced any observed performance enhancements.
The Purpose of This Study
Given the inconclusive nature of research focusing on caffeine’s efficacy as a supplement
capable of enhancing anaerobic performance, more research into the matter could provide insight
into efficacy and provide data pertinent to understanding what mechanisms play a role in
performance enhancements. This study was conducted with the purpose of assessing the affect
that caffeine supplementation has on the anaerobic performance of individuals that are
anaerobically trained. Additionally, proposing potential mechanisms underlying any
improvements detected during data collection by assessing surface electromyography (sEMG) of
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the vastus lateralis and medial head of the gastrocnemius, autonomic nervous system activity via
HRV, and vertical jump performance.
METHODOLOGY
Subject Recruitment
Participants were recruited from Western Michigan University’s student body and the
surrounding community. The criteria for participation required that prospective participants be
individuals over the age of 18 years that engage in regular training focused on improving
anaerobic performance. Individuals that met this requirement reported engaging in 30 minutes of
anaerobic training – e.g. Olympic style weight lifting, High Intensity Interval Training (HIIT)
that utilized powerful muscular contractions, sport specific training for anaerobic activities such
as sprinting, shot put, football, basketball, high jump, and martial arts, or any training that placed
an emphasis on maintaining or improving power output – at least three times per week.
Additionally, participants were required to be generally healthy with no injuries to the lower
extremities occurring within the 6 months prior to participation and no health conditions that
warrant abstinence from caffeine ingestion.
Eleven young adults (demographic data reported in Table 1) determined to fit the training
criteria for participation within this study were asked to visit the Human Performance Research
Laboratory located within the Student Recreation Center at Western Michigan University on two
separate occasions separated by at least 48 hours. It was requested that participants abstain from
ingesting any products or supplements containing caffeine for 48 hours prior to their scheduled
data collection sessions. Upon entering the laboratory for the first session of data collection,
subjects were immediately presented with the informed consent form for review and signing.
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Once the subjects agreed to participate and signed the informed consent form, the PAR-Q+ and
ACSM Health Screening form were administered. The protocol of this study was approved by
Western Michigan University’s HSIRB.
Table 1: Demographics of Participants
N=11 (10 males; 1 female)

Mean

Standard Deviation

Age (years)

23.45

1.51

Height (meters)

1.76

.058

Mass (kilograms)

83.77

12.25

Body Mass Index (kg/m2)

26.93

3.87

Equipment
EKG recordings were collected using a 3-lead BIONOMADIX EKG module (Biopac
Systems, Inc.). HRV was derived from EKG recordings using acqKnowledge (Biopac Systems,
Inc.) sampling at 2,000 HZ. Surface EMG was measured using DTS Lossless wireless surface
EMG modules (Noraxon USA, Inc.). Data collected via sEMG measurements were analyzed with
myoMUSCLE software module and processed through rectification and waveform smoothing.
Lastly, vertical jump height was measured via the Just Jump or Just Run (Probotics, Inc.) mat.
Treatments
Capsules containing caffeine anhydrous USP (NutraBio Labs, Inc.) were used to create the
caffeinated treatment. For the caffeinated treatment, the contents of caffeine capsules were
emptied into a weighing tray placed on a scale until the appropriate amount for the participant’s
body mass was accumulated in the tray (6 mg∙kg-1) and then mixed into 16 ounces (oz.) of tap
water flavored with Mio Liquid Enhancer – Original (Kraft Foods, H.J. Heinz Company Brands
LLC.). The placebo treatment consisted of flavored tap water (16 oz.) with no caffeine added to
it.
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Experimental Procedures
Once determined to fit the criteria for participation, subjects had EKG electrodes in a CM5lead configuration and two sEMG modules placed on their dominant leg; one located over the
vastus lateralis and one located over the medial head of the gastrocnemius. Once all equipment
for data collection was placed, a 5-minute resting EKG recording was performed for assessment
of pre-treatment HRV. Immediately following the EKG recording, the participants performed a
5-minute warm-up focusing on the musculature involved in the performance of a vertical jump.
The warm-up consisted of 3 minutes of treadmill walking that began at a speed of 1.5 miles per
hour which progressed in increments of .5 miles per hour at the completion of each minute, 45
seconds of butt-kickers, 45 seconds of high knees, and 30 seconds of bodyweight squats at a selfselected depth and pace. Following the completion of the warm-up, subjects began the preintervention vertical jump assessments. Jumps were performed on a Just Jump or Just Run jump
mat (Probotics, Inc.), and the subjects were instructed to jump as high as possible with their
hands placed on their hips to avoid any influence of upward momentum, generated via upward
arm swinging, on vertical jump height. The jump protocol consisted of 3 static vertical jump
trials with each jump trial being separated by 2 minutes of rest, a 5-minute resting period, and
then 3 countermovement vertical jump trials with each jump trial being separated by 2 minutes
of rest. The order in which jumps of the specified techniques were performed was not
counterbalanced. During the duration of each jumping technique, EKG was recorded – with one
recording being performed during the static vertical jump trials and another recording being
performed during the countermovement vertical jump trials. Individual EMG measurements
were recorded during each vertical jump trial. Upon the completion of the pre-intervention
vertical jumps, the participants were given a 16-ounce beverage that contained either a placebo
8

treatment or a treatment containing 6 mg∙kg-1 of caffeine. The order in which treatments were
administered was randomized, and subjects were blinded to the treatment order. Subjects were
given 5 minutes to consume the beverage. Once the beverage was consumed, a 60-minute
absorption period began in which the participants were instructed to remain in the lab without
performing any physical activity. Upon the completion of the absorption period, a 5-minute
resting EKG recording, 5-minute warm-up, and the post-intervention jump assessments were
performed with adherence to the same protocol as the pre-intervention warm-up and vertical
jump assessments.
Jump Technique
Vertical jump height is determined by the amount of force that an individual can generate
during the phase of the movement in which the individual propels his/her body upwards – the
more force that is generated, the greater the height of the vertical jump. The depth of the squat
performed immediately prior to upward propulsion may influence vertical jump height.
However, only one study performed with human subjects and simulation modelling by Domire
and Challis (2007) that sought to assess the influence of squat depth on vertical jump height
could be found. Domire and Challis (2007) reported no difference in vertical jump performance
when comparing squat depths. Due to the lack of research regarding optimal squat depth for
performance of the vertical jump and the focus of our study, which did not involve identifying
the optimal squat depth for achieving maximal vertical jump height, participants were allowed to
self-select the depth to which they squatted when performing vertical jumps. When performing
static vertical jump trials, participants were instructed to pause for 1 second once their desired
squat depth was reached and avoid squatting down further after the pause period prior to
initiating upward propulsion to ensure that no countermovement was incorporated into the static
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vertical jump. Any static vertical jump trial during which participants added countermovement to
the jump was thrown out, and participants were asked to repeat the trial. Additionally, all vertical
jumps were performed with the participants hands placed upon their hips. This ensured that no
upward directed force that may influence vertical jump height was generated via upward directed
arm swinging. Lastly, the vertical jump assessment protocol was similar to one previous study
conducted by Bloms, Fitzgerald, Short, and Whitehead (2016). The protocol of our study’s
vertical jump assessments differed from that which was utilized by Bloms and colleagues, as our
study incorporated pre-intervention assessments of vertical jump, 2 minutes of rest between trials
of the same vertical jump technique, and 5 minutes of rest between jumping techniques. The
protocol of our study provided 2 minutes for recovery following the performance of each
individual jump trial and 5 minute between the series of jump trials for each jumping technique
in an effort to eliminate any influence of fatigue on the performance of each jump trial that was
subsequent to a previous trial.
Variables Analyzed
The frequency domain indices of HRV derived from EKG recordings performed prior to
the standardized warm-ups and during the assessments of vertical jump, vertical jump height,
peak power (calculated using the Harman equation (Harman et al., 1991)), and sEMG were
compared for differences between pre and post-intervention assessments and across conditions.
Stretch shortening cycle utilization was assessed by calculating the eccentric utilization ratio
(McGuigan, Doyle, Newton, Edwards, Nimphius, and Newton, 2006).
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Statistical Analysis
Paired-samples T-tests were used to assess the data collected for significant differences
between postintervention data from both conditions (placebo vs. caffeine treatment).
Significance was determined using two-tailed tests with the significance set a priori at p< 0.05.
Additionally, paired-samples T-tests were performed on pre-intervention and post-intervention
data for each condition.
RESULTS
Vertical Jump Height
Significant difference (Figure 1) in post-treatment peak countermovement vertical jump
height between conditions was found (mean ± s.d.: placebo; 56.3 ± 9.33cm; caffeine; 58.5 ±
8.36cm; p=0.018, t= -2.822, df=10). Significant differences were found between pre and postintervention measures of peak countermovement vertical jump height (pre: 55.83 ± 8.26cm; post:
58.50 ± 8.36cm; p=0.001, t=-4.707, df=10) in the caffeine condition (Figure 2). No significant
differences in post-treatment peak static vertical jump height (cm) between conditions were
detected (mean ± s.d.: placebo; 53.34 ± 9.85; caffeine; 55.35 ± 7.88; p>0.05). No significant
differences (p>0.05) were detected for pre and post-intervention measures of peak static vertical
jump under the caffeine condition. Additionally, no significant differences in pre and postintervention measures for both peak countermovement vertical jump height and peak static
vertical jump height under the placebo condition were detected.
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Figure 1: Post-Treatment Vertical Jump Height Data by Condition
CMJ = countermovement vertical jump technique; Static VJ = static vertical jump technique
* p= 0.018 when compared to post-treatment peak countermovement vertical jump height in the
placebo condition, N=11
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Figure 2: Pre and Post-Treatment Vertical Jump Height – Caffeine Condition
CMJ = countermovement vertical jump technique
* p= 0.001 when compared to pre-treatment CMJ height in the caffeine condition, N=11
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Peak Power Calculations
Significant differences (Figure 3) in post-treatment peak power output (W) between
conditions for countermovement vertical jump (placebo; 8204.7 ± 577.5; caffeine; 8638.5 ±
543.1; p<0.001, t= -6.739, df=10) were observed. Also, significant differences (presented in
Figure 3) were found for pre and post-treatment assessments of peak power within the
countermovement vertical jump (pre: 8154.5 ± 511.5; post: 8638.5 ± 543.1; p<0.001, t= -6.842,
df=10) in the caffeine condition. No significant differences were found between any measures of
static vertical jump power (p>0.05).

9500
9300
9100

Peak Power (W)

8900
8700
8500
8300
8100
7900
7700
7500

Post-Treatment
Placebo

Pre-Treatment

Post-Treatment

Caffeine

Figure 3: CMJ Peak Power by Condition
CMJ = countermovement vertical jump technique; W = Watts
* p<0.001 when compared to post-treatment peak CMJ power from placebo condition, N=11
** p<0.001 when compared to pre-treatment peak CMJ power from caffeine condition, N=11
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Stretch Shortening-Cycle Utilization
No differences between post-treatment calculations of eccentric utilization ratio (p>0.05)
were detected. However, significant differences (Figure 4) between the pre and post-treatment
eccentric utilization ratios were present in both the placebo (mean ± s.d; pre: 1.014 ± 0.0496;
post: 1.060 ± 0.0728; p=0.013, t= -3.017, df=10) and caffeine (pre; 1.027 ± 0.0843; post; 1.060 ±
0.083; p=0.025, t= -2.641, df=10) conditions.

1.2

Eccentric Utilization Ratio

1.15
1.1
1.05
1
0.95
0.9

Pre-Treatment Post-Treatment Pre-Treatment Post-Treatment
Placebo

Caffeine

Figure 4: Stretch-Shortening Cycle Utilization
* p=0.013 when compared to pre-treatment eccentric utilization ratio in the placebo condition,
N=11
** p=0.025 when compared to pre-treatment eccentric utilization ratio in the caffeine condition,
N=11
HRV and Surface Electromyography
No significant differences (p>0.05) of sEMG measures at the site of the vastus lateralis or
gastrocnemius were detected between conditions nor pre and post-treatment measures. No
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significant differences (p>0.05) between conditions, nor between pre and post-intervention
measures, were detected when analyzing the frequency domain measures of HRV.
DISCUSSION
Effect of Caffeine Ingestion on Frequency Measures HRV
Analysis of the data collected during this study found that caffeine ingestion did not
significantly affect the frequency domain measures of HRV. These findings were inconsistent
with the previous research that could be found focusing on caffeine’s effect on HRV. The dosage
of caffeine that was utilized in this study (6mg∙kg-1) was greater than the dosages utilized in
similar research that found significant differences in HRV measures, so it had been hypothesized
that alterations in HRV would have been observed in this study. However, no information was
collected regarding participant’s caffeine usage. If the participants in study were habitual
caffeine users, desensitization to caffeine’s effects may explain the lack of significant changes in
frequency domain measures of HRV. Dividing participants into habitual and non-habitual
caffeine users to compare the effects of caffeine ingestion on HRV measures of participants from
each classification could be the goal of future research.
Effect of Caffeine Ingestion on Surface Electromyography
This study’s results suggest that caffeine has no significant effect on measures of peak
sEMG. Since peak amplitude of sEMG did not significantly change at either site, the vastus
lateralis or gastrocnemius, the observed improvements in peak power and peak
countermovement vertical jump height do not appear to be the result of significant alterations in
muscle activation. Caffeine is understood to have a stimulatory effect on the central nervous
system (Dunwiddie, 1985) and has been suggested to cause an increase in excitation of motor
15

neurons (Bazzucchi et al., 2011). The lack of significant increases in peak sEMG measures via
caffeine supplementation may be due to the participants’ habits regarding caffeine usage; it may
be the case that desensitization to caffeine’s effects may have limited changes in sEMG
measures. As was mentioned in the discussion of this study’s data related to frequency domain
measures of HRV, future research could focus on identifying how caffeine may differ in its
effects on sEMG measures performed on habitual and non-habitual caffeine users.
Effect of Caffeine Ingestion on Measures of Vertical Jump Performance
It was hypothesized that caffeine ingestion would result in significant increases in vertical
jump height, peak power output, stretch-shortening cycle utilization, and frequency measures of
HRV. It was thought that increases in frequency measures of HRV as a result of caffeine
supplementation would be indicative of greater nervous system reactivity and be accompanied by
improvement in countermovement vertical jump performance; induced by increased muscle
spindle reactivity to the stretch of the muscles of the lower extremity during eccentric phase of
the countermovement vertical jump. Although this study found no significant effect of caffeine
on peak static vertical jump performance, analysis of vertical jump data found that caffeine
supplementation resulted in a significant improvement in peak countermovement vertical jump
height and peak power calculations (placebo vs. caffeine and pre- vs. post-treatment for
countermovement vertical jump in the caffeine condition). These results do not appear to be in
full agreement with other studies that reported an improvement in vertical jump performance as a
result of caffeine supplementation. For instance, a study conducted by Bloms and colleagues
(2016) and a study conducted by Del Coso and colleagues (2014) both reported a significant
improvement in static and countermovement vertical jump performances when participants
received a treatment containing, respectively, 5 mg∙kg-1 and 3 mg∙kg-1 of caffeine. The disparity
16

between enhancements of vertical jump performance resulting from caffeine supplementation is
intriguing because it would be assumed that any alterations caused by caffeine that would
increase the capability for force production would be evident regardless of jumping technique.
As this was not the case, it suggests that caffeine had an effect that improved the ability of the
eccentric phase of the movement to facilitate force production during the jump’s concentric
phase.
The improvements in vertical jump performance that were observed during this study do
not appear, based upon the data collected and analyzed within this study, to be caused by an
increase in peak muscle activation of two major muscles contributing to knee extension and
plantar flexion as no statistically significant differences in sEMG measurements were observed
between the placebo and caffeine condition, nor when comparing pre and post-treatment sEMG
measures within the caffeine condition. However, caffeine’s known stimulatory effect on the
nervous system may suggest an alternative mechanism through which countermovement vertical
jump performance, but not static vertical jump performance, was improved. The muscle spindles
are thought to contribute to the power produced during concentric phases of movements that
occur immediately after an eccentric phase via afferent signals that travel to the spinal cord from
the muscle spindles which facilitates muscle contraction (Trimble, Kukulka, and Thomas, 2000).
In Trimble and colleagues’ study (2000), simulating afferent signals from muscle spindles during
maximal voluntary isometric contractions of the soleus and gastrocnemius resulted in a
significant increase in sEMG recordings measured over the soleus and lateral gastrocnemius.
Considering Trimble and colleagues’ findings, improvements in countermovement vertical jump
performance that were elicited via caffeine supplementation and unaccompanied by
improvements in static vertical jump may be produced, in part, by strengthening of the afferent
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signals originating at the muscle spindles of muscles involved in performance of the vertical
jump. However, this suggestion is brought into question by the lack of data collected regarding
afferent activity of muscle spindle activity.
Additionally, research using animal models has suggested that caffeine increases the
release of calcium by the sarcoplasmic reticulum and increases force of contraction (Fryer and
Martin, 1989). Additionally, a study by Allen and Westerblad (1995) found that in the presence
of caffeine, myofibrillar proteins were more sensitive to calcium. It may be possible that
enhancement in the performance of ballistic actions (e.g. vertical jump) is the result of muscular
contraction and force generation being supported via a combination of increased release of
calcium by the sarcoplasmic reticulum and increased myofibrillar proteins’ sensitivity to the
elevated levels of calcium. However, if this were the sole explanation of the findings from our
study, it could be expected that significant improvements in both techniques of vertical jump
rather than countermovement vertical jump alone would have been observed. Though
performance of both vertical jump techniques did improve, the fact that the performance of the
countermovement vertical jump displayed the greatest improvement suggests that alterations in
the functioning of components involved in the stretch-shortening cycle were major factors
contributing to the observed performance enhancements. However, no data was collected in an
attempt to quantify afferent signals produced by the muscle spindles throughout the stretchshortening cycle. Although the variables measured in this study did not include calcium release
by the sarcoplasmic reticulum, myofibrillar sensitivity to calcium, nor afferent signals from
muscle spindles, the nature of the observed differences within this study leads us to posit that,
perhaps, a synergistic effect of strengthening of the muscle spindles’ afferent signals in response
to the eccentric phase of the countermovement jump increased calcium release by the
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sarcoplasmic reticulum and increased sensitivity of the myofibrillar proteins to calcium, thus
resulting in greater force production during the concentric phase of the countermovement vertical
jump and greater peak countermovement vertical jump height.
CONCLUSION
The results of this study suggest that caffeine supplementation is beneficial to the
performance of anaerobic activities by individuals that perform regular training focused on
improving anaerobic performance. Though statistical significance was only achieved in the
improvement in countermovement vertical jump performance, investigation of the data collected
presents increases in the mean static vertical jump height with caffeine supplementation. Simple
interpretation of the data collected during this study finds improvements in the measures of
anaerobic performance with the greatest enhancements being limited to movements that
incorporate the stretch-shortening cycle.
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Appendix B: ACSM Pre-Participation Health Screening Form
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Appendix C: Data Collection Form
Participant I.D. :
Date:
Height:

cm

Weight:

kg

Treatment (A or B):
Absorptive-Period Initiation Time:

Static Jump
Vertical Jump Height (Inches)

Trial #

Pre-Intervention

Post-Intervention

1
2
3

Countermovement Jump
Vertical Jump Height (Inches)

Trial #

Pre-Intervention

1
2
3
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Post-Intervention

Participant Name

Appendix D: Participant Master Sheet
Testing Date/Time
Participant I.D.
Placebo
6 mg ∙ kg-1
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Appendix E: Participant Recruitment Flyer
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Institutional Review Board
fWAOOOCH042
IRB00000254
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Date:

March 15, 2019

To:

Timothy Michael, Principal Investigator
Sangwoo Lee, Co-Principal Investigator
Collin Garner, Student Investigator for thesis

From: Arny Naugle, Ph.D., Ch�
Re:

IRB Project Number 18-12-01

This letter will serve as confirmation that the changes to your research project titled "Effect of
Caffeine Supplementation on Vertical Jump Performance, Heart Rate Variability, and
Electromyography" requested in your memo received March 13, 2019 (to revise the number of
data collection sessions from 3 to 2; to change EMO module to Noraxon; to change electrode
placement to chest; to add warm-up prior to post-intervention jump; to perform EKG and EMO
recordings for 5 minute intervals prior to warm up and after 60 minute absorption period; to
calculate peak power using body mass and vertical jump data; to remove 3mg/kg caffeine
condition; to increase session time by 10 minutes; to revise variables due to equipment change;
to revise recruitment and consent materials to reflect these changes) have been approved by the
WMU Institutional Review Board.
The conditions and the duration of this approval are specified in the Policies of Western
Michigan University.
Please note that you may only conduct this research exactly in the form it was approved. You
must seek specific board approval for any changes in this project. You must also seek reapproval
if the project extends beyond the termination date noted below. In addition if there are any
unanticipated adverse reactions or unanticipated events associated with the conduct of this
research, you should immediately suspend the project and contact the Chair of the IRB for
consultation.
The Board wishes you success in the pursuit of your research goals.
January 9, 2020

Approval Termination:
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PHONE (269) 387-8293 FAX: (269) 387-8276
WEBSITE, wmich .edu/research/compliance/hsirb
CAMPUS SITE: Room 251 W. Walwood Hall
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Appendix I: Informed Consent Form

Western Michigan University
IRB
Approved for use for 1 year from this date:

\ JAN 1 0 2019

LI

,r

x�
W IRB�;\
e
Western Michigan University
Human Performance Health Education
Principal Investigator: Dr. Timothy Michael
Co-Principle Investigators: Dr. Nicholas Hanson & Dr. Sangwoo Lee
Student Investigator: Collin Garner & Kyle Derosia
Title of Study: Effect of caffeine supplementation on vertical jump performance, heart rate
variability, and electromyography
You have been invited to participate in a research project titled "Effect of caffeine
supplementation on vertical jump performance, heart rate variability, and
electromyography". This consent document will explain the purpose of this research
project and will go over all of the time commitments, the procedures used in the study, and the
risks and benefits of participating in this research project. Please read this consent form
carefully and completely and please ask any questions if you need more clarification.
What are we trying to find out in this study?
We wish to find out more about how caffeine affects the frequency domain indices of heart rate
variability and aspects of vertical jump (vertical jump height, peak power, and stretch-shortening
cycle).
Who can participate in this study?
You must be 18 years or older. You may not have sustained a lower extremity musculoskeletal
injury (i.e. sprained ankle etc.) or surgery within the last 6 months. You must be able to engage
in maximal exertion vertical jump assessments. An American College of Sports Medicine
(ACSM) health screening document will be filled out to determine the level of risk you are
classified for cardiovascular disease (CVD). If you have too many risk factors, you will not be
able to participate in this study. You will also complete a PAR-Q+ (the Physical Activity
Readiness Questionnaire + ); a questionnaire that was developed as a screening tool to be used to
determine whether an individual is healthy enough to participate in physical activity.
Where will this study take place?
This study will take place in the Human Performance Research Lab located in the lower level of
Western Michigan University's Student Recreational Center.
What is the time commitment for participating in this study?
We will ask you to come to the lab on two occasions. The time commitment for each visit will be
approximately 1 hour and 30 minutes. For 60 of these minutes, you must remain in the lab, but
you can do whatever you like that does not involve physical activity (reading, homework, tasks
for work, etc.).
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